Check Before You Invest : Unihealth Hospitals Ltd

Q: Which industry/sub-sector does Unihealth Hospitals Ltd belong to?

Unihealth Hospitals Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q: Is Unihealth Hospitals Ltd a good quality company?

Unihealth Hospitals Ltd is a weak quality company, based on a inconsistent multi-year financial track record. This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q: Is Unihealth Hospitals Ltd undervalued or overvalued?

Unihealth Hospitals Ltd appears Overvalued, as its key valuation ratios are higher than their past averages. Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more. Valuation Ratios. Price to Earnings, Current: 192.59, Historic Median: 117.08. Price to Book, Current: 16.02, Historic Median: 3.63. Price to Sales, Current: 191.15, Historic Median: 79.04. EV to EBITDA, Current: 135.96, Historic Median: 73.83

Q: Is Unihealth Hospitals Ltd a good buy now?

Unihealth Hospitals Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Q: Revenue growth of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd revenue growth is 83.7% for FY-2026, which is above its 5-year CAGR of 59.68%, indicating faster growth.

Q: Gross Profit margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Gross profit margin which is the profit after deduction of direct costs, is 138.7% for FY-2026, which is above its 5-year median of 93.2%, indicating increasing margins.

Q: Operating Profit Margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 37.98% for FY-2026, which is in line with its 5-year median of 37.98% indicating stable margins.

Q: Net Profit Margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Net Profit Margin is 99.26% for FY-2026, is above its 5-year median of 69.45%, indicating increasing margins. Profitability Metrics. Gross Profit Margin (%), Current: 138.7, Historic Median: 93.2. Operating Profit Margin (%), Current: 37.98, Historic Median: 37.98. Net Profit Margin (%), Current: 99.26, Historic Median: 69.45

Q: Return on Asset of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Return on Asset is 8.53%, which is above its 5-year historical median of 6.13%, indicating improved asset utilization efficiency.

Q: Return on capital employed (ROCE) of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Return on capital employed is 12.02% for FY-2026, which is above its 5-year historical median of 10.58%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Check Before You Invest : Unihealth Hospitals Ltd

Snapshot

Q.1 Which industry/sub-sector does Unihealth Hospitals Ltd belong to?

Unihealth Hospitals Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.2 Is Unihealth Hospitals Ltd a good quality company?

Unihealth Hospitals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q.3 Is Unihealth Hospitals Ltd undervalued or overvalued?

Unihealth Hospitals Ltd appears Overvalued, as its key valuation ratios are higher than their past averages.

Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more.

Valuation Ratios	Current	5-year Historic Median
Price to Earnings	192.59	117.08
Price to Book	16.02	3.63
Price to Sales	191.15	79.04
EV to EBITDA	135.96	73.83

Q.4 Is Unihealth Hospitals Ltd a good buy now?

Unihealth Hospitals Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

A: What are the trends in revenue and profit margins?

Q.1 Revenue growth of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd revenue growth is 83.7% for FY-2026, which is above its 5-year CAGR of 59.68%, indicating faster growth.

Q.2 Gross Profit margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Gross profit margin which is the profit after deduction of direct costs, is 138.7% for FY-2026, which is above its 5-year median of 93.2%, indicating increasing margins.

Q.3 Operating Profit Margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 37.98% for FY-2026, which is in line with its 5-year median of 37.98% indicating stable margins.

Q.4 Net Profit Margin of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Net Profit Margin is 99.26% for FY-2026, is above its 5-year median of 69.45%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin (%)	138.7	93.2
Operating Profit Margin (%)	37.98	37.98
Net Profit Margin (%)	99.26	69.45

B: Does the business utilize capital efficiently?

Q.5 Return on Asset of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Return on Asset is 8.53%, which is above its 5-year historical median of 6.13%, indicating improved asset utilization efficiency.

Q.6 Return on capital employed (ROCE) of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Return on capital employed is 12.02% for FY-2026, which is above its 5-year historical median of 10.58%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.7 Return on Equity (ROE) of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Return on equity is 8.98% for FY-2026, which is above its 5-year historical median of 7.87%, indicating the business is making better use of its shareholders capital.

Q.8 Cash conversion cycle of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Cash conversion cycle is 184 days, below its 5-year historical median of 236 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover (x)	0.09	0.09
ROE (%)	8.98	7.87
ROCE (%)	12.02	10.58
Cash Conversion Cycle	184 days	236 days

C: How much debt does the business have and is it at a sustainable level?

Q.9 Debt to Equity ratio of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Debt-to-Equity ratio is 0.00, which is lower the industry average of 0.20, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

D: Promoter shareholding and pledge status of Unihealth Hospitals Ltd?

Q.1 Promoter shareholding and pledge status of Unihealth Hospitals Ltd?

Promoters hold 69.53% of the Unihealth Hospitals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

E: How does Unihealth Hospitals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Unihealth Hospitals Ltd vs industry peers?

Unihealth Hospitals Ltd revenue CAGR is 59.68%, compared to the industry median CAGR of 2.98%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth (%)	83.7	3
Gross Profit Growth (%)	125	19
Operating Profit Growth (%)	0	15.4
Net Profit Growth (%)	200	22.8

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover (x)	0.09	0.73
ROE (%)	8.98	13.88
ROCE (%)	12.02	17.77
Cash Conversion Cycle (days)	183.53	-

Valuation & price assessment

Q.1 Stock return of Unihealth Hospitals Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of 365.24% based on the current price.

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-	365.2%

Q.2 Valuation ratios of Unihealth Hospitals Ltd vs historical?

The current P/E ratio of 192.59 is higher than its historical median of 117.08, indicating that the stock is trading above its historical average valuation.

Q.3 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	192.59	117.08	37.25
Price to Book	16.02	3.63	3.64
Price to Sales	191.15	79.04	4.21
EV to EBITDA	135.96	73.83	17.66

Check more companies

1. Global Health

2. Krishna Inst.Medi

3. Dr. Lal Pathlabs

4. Dr. Agarwals Health

5. RainbowChildrenS Med

6. Vijaya Diagnostic

7. Park Medi World

8. Metropolis Health.

9. Jupiter Life Line

10. Healthcare Global

Check trending companies

1. Netweb Technologies India Ltd.

2. SBI Cards And Payment Services Ltd.

3. CG Power and Industrial Solutions Ltd.

4. Adani Enterprises Ltd.

5. Ircon International Ltd.

Check Before You Invest : Unihealth Hospitals Ltd

Snapshot

Performance Analysis

Ownership & governance

Peer comparison (industry-wise, mcap)

Profit Metrics

Operating Efficiency

Valuation & price assessment

Check more companies

Check trending companies

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.